MC-1-F2

• CAT Number: I031641
• CAS Number: 2376894-10-7
• Molecular Formula: C37H46N16O2
• Molecular Weight: 746.89
• Purity: 98%
• Synonyms: MC1F2; MC 1 F2; MC-1-F2; MC1-F2; MC-1F2
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 2-[4-[[4-[4-[4-amino-6-(4-morpholin-4-ylanilino)-1,3,5-triazin-2-yl]piperazin-1-yl]-6-(4-phenoxyanilino)-1,3,5-triazin-2-yl]amino]butyl]guanidine
• InChI: InChI=1S/C37H46N16O2/c38-31(39)41-16-4-5-17-42-33-47-35(44-27-10-14-30(15-11-27)55-29-6-2-1-3-7-29)50-37(48-33)53-20-18-52(19-21-53)36-46-32(40)45-34(49-36)43-26-8-12-28(13-9-26)51-22-24-54-25-23-51/h1-3,6-15H,4-5,16-25H2,(H4,38,39,41)(H3,40,43,45,46,49)(H2,42,44,47,48,50)
• InChIKey: COSUURDQUHTOIY-UHFFFAOYSA-N
• SMILES: C1CN(CCN1C2=NC(=NC(=N2)NC3=CC=C(C=C3)N4CCOCC4)N)C5=NC(=NC(=N5)NC6=CC=C(C=C6)OC7=CC=CC=C7)NCCCCN=C(N)N

MC-1-F2（Cat No.:I031641）is a synthetic small molecule compound being researched for its potential as a therapeutic agent in oncology. It is designed to target and modulate specific cellular pathways involved in tumor growth, metastasis, and resistance to conventional therapies. The compound has shown promise in preclinical studies for its ability to inhibit cancer cell proliferation and induce apoptosis in various cancer types. MC-1-F2 is also being evaluated for its potential to overcome drug resistance and enhance the efficacy of other cancer treatments. Further clinical research is needed to assess its safety and therapeutic potential.

Reference

1: Castaneda M, Chen L, Pradhan L, Li S, Zein R, Lee Y, Lim HS, Nam HJ, Lee J. A Forkhead Box Protein C2 Inhibitor: Targeting Epithelial-Mesenchymal Transition and Cancer Metastasis. Chembiochem. 2018 Jul 4;19(13):1359-1364. doi: 10.1002/cbic.201800022. Epub 2018 May 30. PubMed PMID: 29577543.